Literature DB >> 17669963

Simultaneous operation for cardiac disease and lung cancer.

Francesco Patanè1, Alessandro Verzini, Edoardo Zingarelli, Michele di Summa.   

Abstract

Concomitant lesions of the heart and lung have been increasing and the issue of performing simultaneous pulmonary resection and cardiac surgery remains controversial. We report a retrospective study of 11 patients (ten male, one female) who underwent simultaneous lung resection and cardiac operation. In all cases the lung resection was performed before heparinization and cardiopulmonary bypass. All patients were discharged in 10 days. We did not have postoperative complications. Follow up mean was 41.2 months/patients. A combined procedure, when possible, avoids other thoracic procedure, permits to improve outcomes and provides economic benefit.

Entities:  

Year:  2002        PMID: 17669963     DOI: 10.1016/s1569-9293(02)00034-8

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  4 in total

1.  Mitral valve replacement and subaortic membrane resection following pneumonectomy.

Authors:  Melih Hulusi Us; Murat Ugurlucan; Murat Basaran; Ozer Selimoglu; Ali Kocailik
Journal:  Case Rep Med       Date:  2010-03-02

2.  Treatment of simultaneously discovered lung cancer and cardiovascular disease: a 20-year single-institution experience.

Authors:  Ryu Kanzaki; Toru Kimura; Tomohiro Kawamura; Soichiro Funaki; Yasushi Shintani; Masato Minami; Shigeru Miyagawa; Koichi Toda; Yoshiki Sawa; Meinoshin Okumura
Journal:  Surg Today       Date:  2016-09-29       Impact factor: 2.549

3.  Combined Off-Pump Coronary Artery Bypass Grafting and Lung Resection in Patients with Lung Cancer Accompanied by Coronary Artery Disease.

Authors:  Ali Yeginsu; Mustafa Vayvada; Burcin C Karademir; Atakan Erkılınç; Ahmet Erdal Tasci; Fuat Buyukbayrak; Emre Gurcu; Cemal Asım Kutlu
Journal:  Braz J Cardiovasc Surg       Date:  2018 Sep-Oct

4.  Perioperative outcomes of combined heart surgery and lung tumor resection: a systematic review and meta-analysis.

Authors:  Shizhao Cheng; Yiyao Jiang; Xin Li; Xike Lu; Xun Zhang; Daqiang Sun
Journal:  J Cardiothorac Surg       Date:  2021-08-09       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.